Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: The Rotterdam Study

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 9, 2006, Pages 3772-3776

  De Voogd, Simone ^a   Wolfs, Roger C W ^a   Jansonius, Nomdo M ^b   Witteman, Jacqueline C M ^a   Hofman, Albert ^a   De Jong, Paulus T V M ^a,c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ALGORITHM; ARTERY CALCIFICATION; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; COHORT ANALYSIS; ECHOGRAPHY; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OPEN ANGLE GLAUCOMA; OPTIC DISK; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VISUAL FIELD; ABDOMINAL AORTA; BLOOD; INTIMA; METABOLISM; MIDDLE AGED; RADIOGRAPHY;

AGED; AORTA, ABDOMINAL; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; COHORT STUDIES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK FACTORS; TUNICA INTIMA;

EID: 33749138235     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1278     Document Type: Article

References (45)

1. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern: Primary Open-Angle Glaucoma. San Francisco: American Academy of Ophthalmology; 2003.
2. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 2nd ed. Savona, Italy: Dogma; 2003.
3. Friedman DS, Wolfs RCW, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
4. Ostrow PT, Miller LL. Pathology of small artery disease. Adv Neurol. 1993;62:93-123.
5. Hayreh SS. Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin. Prog Retin Eye Res. 1999;18:191-221.
6. Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med. 2004;45:1898-1907.
7. Bots ML, Hofman A, De Jong PTVM, Grobbee DE. Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery: the Rotterdam Study. Ann Epidemiol. 1996;6:147-153.
8. Witteman JCM, Grobbee DE, Valkenburg HA, Van Hemert AM, Stijnen T, Hofman A. Cigarette smoking and the development and progression of aortic atherosclerosis: a 9-year population-based follow-up study in women. Circulation. 1993;88:2156-2l62.
9. Bots ML, Van Swieten JC, Breteler MMB, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet. 1993;341:1232-1237.
10. Labarrere CA, Zaloga GP. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med. 2004;117:499-507.
11. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004;44:6-11.
12. Van der Meer IM, De Maat MP, Bots ML, et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2002;22:838-842.
13. Venugopal SK, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens. 2005;14:33-37.
14. Wolkowicz MI, Hallett JW, Leopold IH. C-reactive protein in ophthalmology; clinical and experimental studies of its use. Am J Ophthalmol. 1956;41:942-950.
15. Leibovitch I, Kurtz S, Kesler A, Feithliher N, Shemesh G, Sela BA. C-reactive protein levels in normal tension glaucoma. J Glaucoma. 2005;14:384-386.
16. Wolfs RCW, Borger PH, Ramrattan RS, et al. Changing views on open-angle glaucoma: definitions and prevalences: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2000;41:3309-3321.
17. Ramrattan RS, Wolfs RCW, Panda-Jonas S, et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study. Arch Ophthalmol. 2001;119:1788-1794.
18. de Voogd S, Ikram MK, Wolfs RCW, Jansonius NM, Hofman A, De Jong PTVM. Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology. 2005;112:1487-1493.
19. Van der Meer IM, Iglesias del Sol A, Hak AE, Bots ML, Hofman A, Witteman JCM. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke. 2003;34:2374-2379.
20. Van der Meer IM, Bots ML, Hofman A, del Sol AI, Van der Kuip DA, Witteman JCM. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004;109:1089-1094.
21. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18:185-192.
22. Dielemans I, Vingerling JR, Hofman A, Grobbee DE, De Jong PTVM. Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefes Arch Clin Exp Ophthalmol. 1994;232:141-144.
23. Skenduli-Bala E, de Voogd S, Wolfs RCW, et al. Causes of incident visual field loss in a general elderly population: the Rotterdam study. Arch Ophthalmol. 2005;123:233-238.
24. Knapp A. Course in certain cases of atrophy of the optic nerve with cupping and low tension. Arch Ophthalmol. 1940;23:41-47.
25. Elwyn H. Calcified carotid artery with atrophy of the optic nerve, cupping and low tension. Arch Ophthalmol. 1940;24:476-478.
26. McLean JM, Ray BS. Soft glaucoma and calcification of the internal carotid arteries. Arch Ophthalmol. 1947;38:154-158.
27. Weinstein P. Data concerning the pseudoglaucoma. Acta Ophthalmol (Copenh). 1963;41:275-278.
28. Drance SM, Sweeney VP, Morgan RW, Feldman F. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 1973;89:457-465.
29. Demailly P, Cambien F, Plouin PF, Baron P, Chevallier B. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica. 1984;188:65-75.
30. Stewart WC, Sorrow NA. Evaluation of non-invasive carotid studies in patients with low-tension glaucoma. Acta Ophthalmol (Copenh). 1994;72:398.
31. Lyons-Wait VA, Anderson SF, Townsend JC, De Land P. Ocular and systemic findings and their correlation with hemodynamically significant carotid artery stenosis: a retrospective study. Optom Vis Sci. 2002;79:353-362.
32. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24:621-664.
33. Gasser P. Why study vascular factors in glaucoma? Int Ophthalmol. 1998;22:221-225.
34. Hayreh SS. The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43(suppl 1): S27-S42.
35. Gherghel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol. 2004;49:491-508.
36. Harris A, Jonescu-Cuypers C, Martin B, Kagemann L, Zalish M, Garzozi HJ. Simultaneous management of blood flow and IOP in glaucoma. Acta Ophthalmol Scand. 2001;79:336-341.
37. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
38. Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol. 2005;16:79-83.
39. Brown CM, Dutsch M, Michelson G, Neundorfer B, Hilz MJ. Impaired cardiovascular responses to baroreflex stimulation in open-angle and normal-pressure glaucoma. Clin Sci (Lond). 2002;102:623-630.
40. Tutaj M, Brown CM, Brys M, et al. Dynamic cerebral autoregulation is impaired in glaucoma. J Neurol Sci. 2004;220:49-54.
41. Hall AJ. Secondary glaucoma. Clin Exp Optom. 2000;83:190-194.
42. Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108:1586-1594.
43. Andersson R, Malmvall BE, Bengtsson BA. Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand. 1986;220:365-367.
44. Borger PH, Van Leeuwen R, Hulsman CA, et al. Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. Ophthalmology. 2003;110:1292-1296.
45. Grodum K, Heijl A, Bengtsson B. Glaucoma and mortality. Graefes Arch Clin Exp Ophthalmol. 2004;242:397-401.